Voyager Therapeutics Inc Stock Ownership - Who owns Voyager Therapeutics?

Insider buying vs selling

Have Voyager Therapeutics Inc insiders been buying or selling?
Alfred SandrockPresident and CEO2024-04-0212,115$9.86
Robin SwartzChief Operating Officer2024-04-021,357$9.88
Todd Alfred CarterChief Scientific Officer2024-02-213,365$7.47
Peter P. PfreundschuhChief Financial Officer2024-02-213,764$7.46
Alfred SandrockPresident and CEO2024-02-2113,033$7.46
Robin SwartzChief Operating Officer2024-02-213,966$7.45
Todd Alfred CarterChief Scientific Officer2024-02-20602$7.68
Todd Alfred CarterChief Scientific Officer2024-01-171,266$7.18
Robin SwartzChief Operating Officer2024-01-172,543$7.15
Peter P. PfreundschuhChief Financial Officer2023-10-0313,567$6.99

1 of 2

VYGR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VYGR insiders and whales buy or sell their stock.

VYGR Shareholders

What type of owners hold Voyager Therapeutics Inc stock?
Neurocrine Biosciences Inc15.77%8,575,316$75.21MInsider
Ecor1 Capital LLC14.94%8,128,014$71.28MInsider
Mark J. Levin11.82%6,427,874$56.37MInsider
Armistice Capital LLC8.59%4,672,000$40.97MInstitution
Blackrock Inc8.08%4,397,444$38.57MInstitution
Ecor1 Capital LLC7.20%3,917,546$34.36MInstitution
Vanguard Group Inc5.94%3,231,698$28.34MInstitution
Farallon Capital Management LLC4.21%2,292,000$20.10MInstitution
State Street Corp3.22%1,749,168$15.34MInstitution

1 of 3

VYGR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VYGR54.30%45.70%Net SellingNet Selling
URGN73.07%26.93%Net BuyingNet Selling
IGMS38.65%54.41%Net BuyingNet Buying
TERN72.36%27.64%Net SellingNet Selling
LXRX19.61%80.39%Net BuyingNet Buying

Voyager Therapeutics Stock Ownership FAQ

Who owns Voyager Therapeutics?

Voyager Therapeutics (NASDAQ: VYGR) is owned by 63.43% institutional shareholders, 53.38% Voyager Therapeutics insiders, and 0.00% retail investors. Neurocrine Biosciences Inc is the largest individual Voyager Therapeutics shareholder, owning 8.58M shares representing 15.77% of the company. Neurocrine Biosciences Inc's Voyager Therapeutics shares are currently valued at $74.35M.

If you're new to stock investing, here's how to buy Voyager Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.